Atea Pharmaceuticals Q3 Earnings Preview: EPS Estimate at (0.51) USD
Atea Pharmaceuticals is scheduled to report Q3'26 results on November 9 after the market close. Revenue is estimated at 0 USD and EPS at (0.51) USD.
AVIR (Atea Pharmaceuticals, Inc.) is set to announce its Q3'26 results on November 09, after the market closes. The earnings are expected to be disclosed at 4:05 PM ET (9:05 PM UTC).For Q3'26, revenue estimate is 0 USD with EPS (earnings per share) anticipated at (0.51) USD. Learn more details at A…